AG002ZJZ

303-26-4 | Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-

AG002ZJZ

SDS

COA

Price

$0.00

WARNING This product is not for human or veterinary use.

CAS Number	303-26-4
Catalog Number	AG002ZJZ(AGN-PC-0WA3QA)
Chemical Name	Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-
EC Number	206-137-4
IUPAC Name	1-[(4-chlorophenyl)-phenylmethyl]piperazine
InChI	InChI=1S/C17H19ClN2/c18-16-8-6-15(7-9-16)17(14-4-2-1-3-5-14)20-12-10-19-11-13-20/h1-9,17,19H,10-13H2
InChI Key	UZKBSZSTDQSMDR-UHFFFAOYSA-N
MDL Number	MFCD00005965
Molecular Formula	C17H19ClN2
Molecular Weight	286.7992
NSC Number	86164
SMILES	ClC1=CC=C(C(N2CCNCC2)C3=CC=CC=C3)C=C1
Synonyms	N-(p-chlorobenzhydryl)piperazine, norchlorcyclizine, norchlorcyclizine hydrochloride, norchlorcyclizine monohydrochloride, 1-(4-Chlorobenzhydryl)piperazine, 303-26-4, Norchlorcyclizine, 1-((4-chlorophenyl)(phenyl)methyl)piperazine, 1-[(4-Chlorophenyl)(phenyl)methyl]piperazine, N-(p-Chlorobenzhydryl)piperazine, 1-[(4-Chlorophenyl)phenylmethyl]piperazine, 4-(4-Chlorobenzhydryl)piperazine, NSC 86164, N-(4-Chlorobenzhydryl)piperazine, 1-[(4-chlorophenyl)-phenylmethyl]piperazine, 1-(4-Chlorobenzhydryl) piperazine, EINECS 206-137-4, 1-(4-Chlorodiphenylmethyl)piperazine, MFCD00005965, Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-, BRN 0243027, 1-(4-Chloro-alpha-phenylbenzyl)piperazine, 1-(alpha-Phenyl-4-chlorobenzyl)piperazine, 1-[(4-chlorophenyl)-phenyl-methyl]piperazine, Piperazine, 1-((4-chlorophenyl)phenylmethyl)-, Piperazine, 1-(alpha-(4-chlorophenyl)benzyl)-, UZKBSZSTDQSMDR-UHFFFAOYSA-N, 4-CHLOROBENZHYDRYLPIPERAZINE, 1-(.alpha.-Phenyl-4-chlorobenzyl)piperazine, 1-(4-Chloro-.alpha.-phenylbenzyl)piperazine, Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-, C17H19ClN2, PIPERAZINE, 1-(p-CHLORO-alpha-PHENYLBENZYL)-, (-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine, 130018-88-1, [(4-chlorophenyl)phenylmethyl]piperazine, 1-((4-chlorophenyl)phenylmethyl)piperazine, 1-[(4-chlorophenyl)phenylmethyl)piperazine, 1-(4-Chlorobenzhydryl)piperazine, 90-95%, 1-((4-Chlorophenyl)(phenyl)methyl)-piperazine, Piperazine, 1-(.alpha.-(4-chlorophenyl)benzyl)-, Piperazine, 1-[.alpha.-(4-chlorophenyl)benzyl]-, 1-(|A-phenyl-4-chlorobenzyl)piperazine, Cetirizine Impurity A, PubChem14572, (S)-Nor-CCZ, AC1L1SUD, AC1Q3IPT, AC1Q3IPU, chlorobenzhydryl piperazine, Levocetirizine Impurity 2, ACMC-1AD0Y, AC1Q3ND4, 4-chlorobenzhydryl piperazine, Oprea1_771131, 4-23-00-00072 (Beilstein Handbook Reference), KSC222M5F, MLS000521343, CHEMBL81324, SCHEMBL467086, GTPL9162, Jsp001819, Jsp005719, CTK1C2652, KS-00000DME, HMS1648P05, HMS2464F07, N-(4-Chlorobenzhydryl) piperazine, ACN-S003156, BCP08791, NSC86164, ANW-26836, BBL010366, NSC-86164, SBB002998, STK083473, AKOS000268792, AKOS016039386, AC-3019, CS-W001978, GF-0133, LS41163, MCULE-4972496755, TRA0080543, 1-(p-Chloro-|A-phenylbenzyl)piperazine, NCGC00245963-01, AK-77432, AK-81977, AN-13404, compound C10 [PMID: 24297249], SC-16682, SMR000131751, ST042038, SY003580, AB0011122, AB1008296, DB-018556, LS-111196, RT-002480, ST2403049, C1611, EU-0099994, FT-0629215, FT-0658637, 1-[(4-chlorophenyl)-phenylmethyl]-piperazine, EN300-18220, MFCD00005965 (95%), M-1342, N-[(4-chlorophenyl)(phenyl)-methyl]piperazine, (-)-1-[(4chlorophenyl) phenylmethyl]piperazine, 1-[(4-Chloro-phenyl)-phenyl-methyl]-piperazine, (-)-1-[(4-chloro phenyl)phenylmethyl]piperazine, (RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine, 303C264, A806004, SR-01000597190, I14-0469, I14-0471, Q-200042, SR-01000597190-1, (-)-1-[(4-Chloro-phenyl)-phenyl-methyl]-piperazine, Piperazine, 1-((4-chlorophenyl)phenylmethyl)- (9CI), Z57388987, 1-(4-Chlorobenzhydryl)piperazine, technical grade, 90%, Meclozine impurity H, European Pharmacopoeia (EP) Reference Standard, Cetirizine impurity A, European Pharmacopoeia (EP) Reference Standard, Hydroxyzine Related Compound A, United States Pharmacopeia (USP) Reference Standard, null, Cetirizine EP impurity A, UNII-T875VN0D6E, T875VN0D6E, C17-H19-Cl-N2, CID9340, KST-1B9434, ACN-S002568, AR-1B3352, ACN-028571, CS-O-31588, (R)-1-((4-chlorophenyl)(phenyl)methyl)piperazine, A5581, (S)-1-((4-chlorophenyl)(phenyl)methyl)piperazine, (+)-1-((4-chlorophenyl)phenylmethyl]piperazine, (+)-1-[(4-Chlorophenyl)phenylmethyl]piperazine, (2S)-2-Methyl-octahydroindole-2-carboxylic acid, (R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine, 1-(4-Chlorobenzhydryl)piperazine, 95% - 1G 1g, 300543-56-0, 439858-21-6, 95028-66-3,

Complexity	277
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	286.124g/mol
Formal Charge	0
Heavy Atom Count	20
Hydrogen Bond Acceptor Count	2
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	286.803g/mol
Monoisotopic Mass	286.124g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	15.3A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	3.4

GHS Hazard and Precautionary Statements

Symbol:
Hazard statements	H315-H319-H335
Precuationary statements	P261-P305+P351+P338
Siginal words

Certificate of Analysis

Lot Number